959 related articles for article (PubMed ID: 25751200)
1. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
3. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
4. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
5. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
Chen F; Bailey CE; Alvarez RD; Shu XO; Zheng W
Gynecol Oncol; 2021 Jan; 160(1):10-15. PubMed ID: 33208254
[TBL] [Abstract][Full Text] [Related]
6. Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy.
Washington CJ; Karanth SD; Wheeler M; Aduse-Poku L; Braithwaite D; Akinyemiju TF
Cancer Causes Control; 2024 Mar; 35(3):487-496. PubMed ID: 37874478
[TBL] [Abstract][Full Text] [Related]
7. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
9. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.
Du XL; Sun CC; Milam MR; Bodurka DC; Fang S
Int J Gynecol Cancer; 2008; 18(4):660-9. PubMed ID: 17892451
[TBL] [Abstract][Full Text] [Related]
10. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
[TBL] [Abstract][Full Text] [Related]
11. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.
Brewer KC; Peterson CE; Davis FG; Hoskins K; Pauls H; Joslin CE
Ann Epidemiol; 2015 Aug; 25(8):556-63. PubMed ID: 25986734
[TBL] [Abstract][Full Text] [Related]
12. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
[TBL] [Abstract][Full Text] [Related]
13. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
14. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
15. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
[TBL] [Abstract][Full Text] [Related]
16. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
[TBL] [Abstract][Full Text] [Related]
17. Disparities in treatment and survival among elderly ovarian cancer patients.
Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
[TBL] [Abstract][Full Text] [Related]
18. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
[TBL] [Abstract][Full Text] [Related]
19. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
[TBL] [Abstract][Full Text] [Related]
20. Association of Hospital Volume With Racial and Ethnic Disparities in Locally Advanced Cervical Cancer Treatment.
Uppal S; Chapman C; Spencer RJ; Jolly S; Maturen K; Rauh-Hain JA; delCarmen MG; Rice LW
Obstet Gynecol; 2017 Feb; 129(2):295-304. PubMed ID: 28079775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]